Therapeutic Cancer Vaccines
Therapeutic Cancer Vaccines and Antiangiogenic Treatments Combinations
Therapeutic Cancer Vaccines and Immune Checkpoint Blockade Combinations
Therapeutic vaccines are that vaccines which are directed after an infection or a disease have already occurred. The therapeutic vaccines works by activating the immunity power of a patient to fight against an infectious disease. There is difference between a therapeutic vaccine and a prophylactic vaccine as the prophylactic vaccines are administered to living organisms as a precautionary measure to prevent the infection or disease while the therapeutic vaccines are administered to individual after the individual is already affected by the disease or infection.
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia, May 2020
Temesgen Azemeraw Yitayew, Addis Ababa University, Ethiopia
Title : Awareness and Acceptability of Rotavirus Vaccine among mothers of under-five children in Gusau and Bungudu c Ommunities of Zamfara State, Northwestern Nigeria
Attahir Abubakar, Ahmadu Bello University , Nigeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India